e-learning
resources
Virtual 2021
07.09.2021
Better understanding of sarcoidosis: new keys
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of Infliximab on FDG Uptake and Small Fiber Neuropathy Symptoms in Sarcoidosis Patients
L. Raasing (Nieuwegein, Netherlands), O. Vogels (Nieuwegein, Netherlands), M. Veltkamp (Nieuwegein, Netherlands), J. Grutters (Nieuwegein, Netherlands)
Source:
Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Session:
Better understanding of sarcoidosis: new keys
Session type:
Oral Presentation
Number:
3984
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Raasing (Nieuwegein, Netherlands), O. Vogels (Nieuwegein, Netherlands), M. Veltkamp (Nieuwegein, Netherlands), J. Grutters (Nieuwegein, Netherlands). Effects of Infliximab on FDG Uptake and Small Fiber Neuropathy Symptoms in Sarcoidosis Patients. 3984
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020
Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020
Modes of Disease Progression in Different Forms of Interstitial Lung Disease with Usual Interstitial Pneumonia Histology in Patients with Idiopathic and Non-idiopathic Etiologies - A Single Center Experience
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Predictors of Progression in Patients with Pulmonary Sarcoidosis
Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases
Year: 2020
Differential Expression of Plasma Metabolites in Patients with Pulmonary Sarcoidosis is Associated with Clinical Behavior
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
Severity of Bronchiectasis and Lung Functions Related with the Genotype of Primary Ciliary Dyskinesia Patients
Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Year: 2020
Clinical and Epidemiological Features of Tumor and Non-tumor Patients Complicated with Pulmonary Embolism
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017
Effects of EXercise TRAining in Sarcoidosis
Source: Eur Respir J 2005; 26: Suppl. 49, 432s
Year: 2005
O'Donnell Criteria as a Score of Bad Prognosis in Hospitalized Patients with Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis, an Observetional Study
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021
Effects of Telerehabilitation on Peripheral Muscle Function in Pediatric Cystic Fibrosis Patients During Covid-19 Pandemic
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021
Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021
IL-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021
Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations?
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
The Effect of Lipid Profile and Obesity on the Grade of Neutropenia in Patients with Small Cell Lung Cancer Treated with Etoposide-Cisplatin as First Regimen.
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019
Local Administration of Targeted Liposomes Loaded with Everolimus for Interstitial Lung Disease in Systemic Sclerosis
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Year: 2021
Quantitative Assessment of Thoracic Muscles in Patients with Idiopathic pulmonary fibrosis :Relationship with Prognosis
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018
Aerobic Training Improves Pulmonary and Systemic Inflammatory and Fibrotic Response in Asthmatics
Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases
Year: 2021
Chest Imaging Abnormalities in Patients with Uncontrolled Rheumatoid Arthritis Prior to Biological Therapy Initiation
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept